Gore Achieves 40 Million Implants Sold Worldwide as it Celebrates 40 Years of Performance

Milestones a testament on its 40-year legacy of designing devices to improve patient outcomes

Flagstaff, Ariz. (November 17, 2015) — W. L. Gore & Associates, Inc. (Gore) today announced in conjunction with its 40th anniversary, it has sold 40 million devices worldwide. The milestones come as the company showcases its latest innovations and achievements for the vascular community at the 2015 VEITHsymposium® in New York.

The medical products division of Gore was formed by Bill Gore with the intent to design an ideal substitute for a human blood vessel using GORE-TEX® ePTFE. Forty years later, Gore is an industry leader in medical devices with more than 40 million devices sold that are designed to treat patients along the entire length of the body.

At VEITHsymposium 2015, Gore is announcing developments to its diverse portfolio of products, including clinical trial developments, as well kicking off the highly anticipated nominations for the 2016-2017 Pioneers in Performance award.

  • The GORE® EXCLUDER® Iliac Branch Endoprosthesis has exceeded 1,000 implants worldwide. This milestone comes only two years after the device received the CE Mark in Europe. The device is currently commercially available in Europe and Australia, in clinical trial in the US, and available through special access in Canada.
  • Gore celebrates its 6th year of the Pioneers in Performance Awards by continuing its tradition of honoring physicians responsible for driving medical innovation and improving clinical and patient outcomes.  The Pioneers in Performance Awards recognize physicians for their commitment to advancing vascular and endovascular therapy and minimally invasive treatment options for patients across the globe. These specialties include aortic and lower-limb bypass, and dialysis access surgery. The nominees will be announced on Tuesday evening and voting for the 2016 Pioneers in Performance Awards for North America will open beginning on Wednesday, November 18, 2015.
  • Global vascular thought leaders will reconvene this week at VEITH for an update on the inaugural Gore-sponsored Surgical Bypass Summit. The group is challenging historic beliefs about surgical bypass and whether there needs to be a change in the current treatment paradigm. Content from the inaugural Surgical Bypass Summit is available at www.surgicalbypass.com.

Gore looks towards the future, continuing to improve lives through advanced materials and delivering meaningful innovations that set the standard of performance.


ABOUT VEITHsymposium 

Now in its 42nd year, VEITHsymposium provides vascular surgeons, interventional radiologists, interventional cardiologists, and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features rapid-fire presentations from world renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies, and new techniques. To register to attend VEITHsymposium, please visit www.VEITHpress.org or contact Pauline T. Mayer at 631.979.3780


ABOUT US

At Gore Medical, we have provided creative therapeutic solutions to complex medical problems for 40 years. During that time, 40 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. Our extensive family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia and soft tissue reconstruction, staple line reinforcement materials, and sutures for use in vascular, cardiac, and general surgery.  We are one of a select few companies to appear on all of the U.S. “100 Best Companies to Work For” lists since the rankings debuted in 1984.

 

Residents of some states have the right to opt-out of the “sharing” or “selling” of their personal information. Gore does not "sell" the personal information of website users. Gore may "share" the personal information of website users, as standard advertising practice meant to offer you a more personalized service.

If you want to opt-out from Gore “sharing” your personal information, click on Opt-Out of Sharing to turn off the targeting cookies that we share with our advertising partners in order to provide you with personalized information. Disabling sharing will stop the use of cookies to targeted advertising but you may still see generic Gore ads.

Please note that your exercising of the rights outlined will have no adverse effect on the price and quality of our goods or services.

Opt-Out of Sharing

You Have Successfully Opted Out of the Sharing of Your Personal Information

Please note that if you clear your cookies and then use another device or browser, etc. your opt-out status is not transferred to the new device or browser.